EFFECTIVE CONTROL, TREATMENT AND PREVENTION OF ANEMIA IN HEART FAILURE AND DISEASES IN THE FERGANA VALLEY

Authors

  • Axunbayev Otabek Adilovich Assistant of Fergana Medical Institute of Public Health

Keywords:

anemia, heart failure, iron deficiency, cardiovascular diseases, erythropoiesis-stimulating agents, hemoglobin, ferritin, NYHA classification, Fergana Valley, cardiorenal syndrome, hospitalization, quality of life, ferrous sulfate, intravenous iron, treatment outcomes.

Abstract

This study examines anemia correction protocols in 284 cardiovascular patients across three clinical centers in the Fergana Valley during 2022-2024. Combined iron supplementation with erythropoiesis-stimulating agents demonstrated hemoglobin elevation from 98.4 g/L to 118.7 g/L over 16 weeks, alongside reduced hospitalization rates by 34% and improved functional capacity in NYHA class II-III patients with concurrent heart failure and iron deficiency anemia.

Downloads

Published

2025-12-31

Issue

Vol. 3 No. 12 (2025): WOM

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

EFFECTIVE CONTROL, TREATMENT AND PREVENTION OF ANEMIA IN HEART FAILURE AND DISEASES IN THE FERGANA VALLEY. (2025). Web of Medicine: Journal of Medicine, Practice and Nursing , 3(12), 441-446. https://webofjournals.com/index.php/5/article/view/5765